Concepedia

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study

Kohei Shitara, Hiroji Iwata, Shunji Takahashi, Kenji Tamura, Haeseong Park, Shanu Modi, Junji Tsurutani, Shigenori Kadowaki, Kensei Yamaguchi, Satoru Iwasa,

The Lancet Oncology · 2019 · 229 citations · 27 references

DOI

Concepts

References

27

Global cancer statistics, 2012

Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text

, , +16

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.3K citations · Full text

, , +17

Japanese gastric cancer treatment guidelines 2014 (ver. 4)

Gastric Cancer · 2016 · 2.5K citations · Full text

, , +10

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Fátima Cardoso, A. Costa, Elżbieta Senkus et al. · Annals of Oncology · 2016 · 2.1K citations · Full text

, , +11

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Elizabeth Smyth, Marcel Verheij, William Allum et al. · Annals of Oncology · 2016 · 1.6K citations

, , +14